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Background: NT pro-brain natriuretic peptide (NT-proBNP) and norepinephrine (NE) levels have been shown to predict mortality in heart failure 
(HF) patients. However, the relation between exercise-induced changes of these biomarkers and clinical outcomes has not been fully elucidated and 
represents the aim of the present investigation.
We prospectively studied 221 HF patients undergoing 3-month aerobic exercise training. Serum NT-proBNP and plasma NE were measured 
at baseline and after training, along with clinical (NYHA class, heart rate), and functional [peak VO2, left ventricular ejection fraction (LVEF)] 
parameters. Cardiac-related mortality was the primary outcome of the study and was evaluated during a mean follow up period of 37±12 months. 
At the end of the training program, we observed a significant improvement of peak VO2, and a significant reduction of plasma NE, serum NT-proBNP 
and heart rate compared to baseline (pre-exercise) values. Exercise similarly reduced NT-proBNP levels in both survivor and non survivor groups. 
Differently, plasma NE decreased and peak VO2 increased in the survivor group, while training did not change their values in the non survivor group. 
Multiple Cox proportional hazard regression analysis, performed using baseline and delta values (post-training vs pre-training values) indicated 
that baseline values NT-proBNP, NE and peak VO2 resulted all predictors of cardiac mortality. Importantly, for delta values, delta NE and delta peak 
VO2 were both predictors of cardiac mortality, whereas, delta LVEF and delta NT-proBNP did not result independent predictors of outcome. Patients 
stratification according to the median value of delta NE allowed to recognize an higly significant increased mortality in patient group below the 
median values with a 24 and 36 months mortality rates of 84% and 95%, respectively.
Our data indicate that exercise-induced changes of plasma NE and peak VO2 might be proposed as useful markers in predicting prognosis in HF. 
Larger prospective studies are needed to verify whether short term change of plasma NE may represent a novel simple surrogate end-point for 
targeting specific therapies and predicting survival in HF patients.
